搜索页_+Exemestane

设为首页

收藏本站

网站地图 | English | 公务邮箱

About the library

Background
History
Leadership
Organization

Readers' Guide

Opening Hours
Collections
Help Via Email

Publications

Electronic Information Resources

常用资源

在“Elsevier电子期刊”中，命中：291条，耗时：0.0139942 秒

1.Cardiotoxicity of Aromatase Inhibitors in Breast Cancer Patients

作者：Jennifer Foglietta¹ ; Alessandro Inno² ; Francesca de Iuliis³ ; Valentina Sini⁴ ; Simona Duranti² ; Monica Turazza² ; Luigi Tarantini⁵ ; Stefania Gori² ; ^{stefania.gori@sacrocuore.it}

关键词：Anastrozole ; Cardiovascular disease ; Exemestane ; Letrozole ; Tamoxifen

刊名：Clinical Breast Cancer

出版年：2017

2.Transcriptional up-regulation of human udp-glucuronosyltransferase (UGT) 2B17 by exemestane and its active metabolite 17-hydroexemestane in breast cancer cells

作者：Apichaya Chanawong¹ ; Dong-Gui Hu¹ ; Robyn Meech¹ ; Ross A. McKinnon² ; Peter I. Mackenzie¹

刊名：Drug Metabolism and Pharmacokinetics

出版年：2017

3.Prolonged response to exemestane following multiple surgical resections and hormonal therapies in a patient with recurrent endometrial stromal sarcoma

作者：Heather Wolfe^a ; ^{heather.l.wolfe14.mil@mail.mil" class="auth_mail" title="E-mail the corresponding author} ; Kristen Bunch^b ; Michael Stany^b

关键词：Endometrial stromal sarcoma ; Hormonal therapy ; Exemestane

刊名：Gynecologic Oncology Reports

出版年：2016

4.Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience

关键词：Everolimus ; Metastatic breast cancer ; Exemestane

刊名：The Breast

出版年：2016

5.Unravelling exemestane: From biology to clinical prospects

作者：Ana Filipa Sobral^a ; ^b ; Cristina Amaral^b ; ^{cristinamaralibd@gmail.com" class="auth_mail" title="E-mail the corresponding author} ; Georgina Correia-da-Silva^b ; Naté ; rcia Teixeira^b ; ^{natercia@ff.up.pt" class="auth_mail" title="E-mail the corresponding author}

关键词：AI(s) ; aromatase inhibitor (s) ; AKT ; protein kinase B ; AREG ; amphiregulin ; BMD ; bone mineral density ; CYP ; cytochrome P450 ; DHEAS ; dehydroepiandrosterone sulfate ; EGF ; epidermal growth factor ; EGFR ; epidermal growth factor receptor ; EMA ; European Medicines Agency ; EORTC ; The European Organization for Research and Treatment of Cancer ; ER ; estrogen receptor ; ER+ ; estrogen receptor positive ; FDA ; U.S Food and Drug Administration ; HDAC ; histone deacetylase ; HER2 ; human epidermal growth factor recept

刊名：Journal of Steroid Biochemistry and Molecular Biology

出版年：2016

6.Exemestane metabolites suppress growth of estrogen receptor-positive breast cancer cells by inducing apoptosis and autophagy: A comparative study with Exemestane

作者：Cristina Amaral^a ; Andreia Lopes^b ; Carla L. Varela^c ; Elisiá ; rio Tavares da Silva^c ; ^d ; Fernanda M.F. Roleira^c ; ^d ; Georgina Correia-da-Silva^a ; Naté ; rcia Teixeira^a ; ^{natercia@ff.up.pt" class="auth_mail" title="E-mail the corresponding author}

关键词：Estrogen receptor-positive breast cancer ; Aromatase inhibitors ; Exemestane metabolites ; Apoptosis ; Autophagy ; Acquired-resistance

刊名：International Journal of Biochemistry and Cell Biology

出版年：2015

7.Dosing and Safety Implications for Oncologists When Administering Everolimus to Patients With Hormone Receptor-Positive Breast Cancer

作者：Hope S. Rugo ; ^{hope.rugo@ucsf.edu" class="auth_mail" title="E-mail the corresponding author}

关键词：Exemestane ; Hormone receptor positive advanced breast cancer ; mTOR inhibition ; Pneumonitis ; Stomatitis

刊名：Clinical Breast Cancer

出版年：2016

8.Are SOFT and TEXT results practice changing and how?

作者：Olivia Pagani^a ; ^b ; ^{olivia.pagani@ibcsg.org" class="auth_mail" title="E-mail the corresponding author} ; Meredith M. Regan^b ; ^c ; Prudence A. Francis^b ; ^d ; ^e

关键词：Premenopausal ; Breast cancer ; Endocrine therapy ; Exemestane ; Ovarian suppression ; Tamoxifen

刊名：The Breast

出版年：2016

9.The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer

作者：Husam Abdel-Qadir^a ; ^b ; ^c ; ^d ; Eitan Amir^a ; ^c ; ^e ; Hadas D. Fischer^b ; Longdi Fu^b ; Peter C. Austin^b ; ^c ; Paula J. Harvey^a ; ^d ; ^f ; ^g ; Paula A. Rochon^a ; ^b ; ^c ; ^d ; ^f ; Douglas S. Lee^a ; ^b ; ^c ; ^g ; ¹ ; Geoffrey M. Anderson^b ; ^c ; ^f ; ¹ ; ^{geoff.anderson@utoronto.ca" class="auth_mail" title="E-mail the corresponding author}

关键词：Hormonal therapy ; Endocrine therapy ; Anastrozole ; Letrozole ; Exemestane ; Coronary artery disease ; Cardio-oncology ; Survivorship

刊名：European Journal of Cancer

出版年：2016

10.Network Meta-Analysis Comparing Overall Survival for Fulvestrant 500 mg Versus Alternative Therapies for Treatment of Postmenopausal, Estrogen Receptor-Positive Advanced Breast Cancer Following Failure on Prior Endocrine Therapy

作者：Claire Telford¹ ; ^{claire.telford@astrazeneca.com" class="auth_mail" title="E-mail the corresponding author} ; Nick Jones¹ ; Christopher Livings² ; Sarah Batson²

关键词：Aromatase inhibitor ; Hormone therapy ; Indirect treatment comparison ; Progression ; Selective estrogen receptor degrader

刊名：Clinical Breast Cancer

出版年：2016

按检索点细分(291)

题名(136)

关键词(69)

文摘(192)

按出版年细分(291)

2027年及以后(5)

2017年(2)

2016年(13)

2015年(8)

2013年(26)

2012年(15)

2011年(20)

2010年(18)

2009年(18)

2008年(19)

2007年(36)

2006年(30)

2005年(19)

2004年(13)

2003年(14)

2002年(2)

2001年(14)

2000年(5)

2000年及以前(14)